Literature DB >> 10680717

Reaction of nitroxyl, an aldehyde dehydrogenase inhibitor, with N-acetyl-L-cysteine.

D W Shoeman1, F N Shirota, E G DeMaster, H T Nagasawa.   

Abstract

Nitroxyl (HNO) is the aldehyde dehydrogenase (AIDH) inhibitor produced by catalase action on cyanamide. Incubation of N-acetyl-L-cysteine (NAC), a reagent with a free sulfhydryl group, with Piloty's acid (a nitroxyl generator) suggested that NAC was acting as a competitive "trap" for nitroxyl. Elucidation of the structure of this reaction product should give an insight as to how nitroxyl interacts with AIDH, a sulfhydryl enzyme. We now present evidence that the product formed is N-acetyl-L-cysteinesulfinamide (NACS). We have synthesized NACS and showed that this synthetic product was identical to the product formed in the trapping experiment. Both had identical RT values by reverse phase HPLC and identical RF values by TLC using three different solvent systems. The structural identification of this nitroxyl trapped product as a sulfinamide now allows the chemical confirmation of the active-site cysteine residue of AIDH as Cys-302.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680717     DOI: 10.1016/s0741-8329(99)00056-7

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  15 in total

Review 1.  The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.

Authors:  Wilmarie Flores-Santana; Debra J Salmon; Sonia Donzelli; Christopher H Switzer; Debashree Basudhar; Lisa Ridnour; Robert Cheng; Sharon A Glynn; Nazareno Paolocci; Jon M Fukuto; Katrina M Miranda; David A Wink
Journal:  Antioxid Redox Signal       Date:  2011-03-16       Impact factor: 8.401

Review 2.  A recent history of nitroxyl chemistry, pharmacology and therapeutic potential.

Authors:  Jon M Fukuto
Journal:  Br J Pharmacol       Date:  2018-07-01       Impact factor: 8.739

3.  Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors.

Authors:  Gail M Johnson; Tyler J Chozinski; Elyssia S Gallagher; Craig A Aspinwall; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2014-07-23       Impact factor: 7.376

4.  Nitroxyl (HNO) acutely activates the glucose uptake activity of GLUT1.

Authors:  Matthew J Salie; Daniel S Oram; David P Kuipers; Jared P Scripture; Jude Chenge; Griffin J MacDonald; Larry L Louters
Journal:  Biochimie       Date:  2011-12-11       Impact factor: 4.079

5.  On the acidity and reactivity of HNO in aqueous solution and biological systems.

Authors:  M D Bartberger; J M Fukuto; K N Houk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

6.  Biological signaling by small inorganic molecules.

Authors:  Debashree Basudhar; Lisa A Ridnour; Robert Cheng; Aparna H Kesarwala; Julie Heinecke; David A Wink
Journal:  Coord Chem Rev       Date:  2016-01-01       Impact factor: 22.315

7.  1H NMR structure of the heme pocket of HNO-myoglobin.

Authors:  Filip Sulc; Everly Fleischer; Patrick J Farmer; Dejian Ma; Gerd N La Mar
Journal:  J Biol Inorg Chem       Date:  2002-12-14       Impact factor: 3.358

8.  Hydroxylamine acutely activates glucose uptake in L929 fibroblast cells.

Authors:  Larry L Louters; Jared P Scripture; David P Kuipers; Stephen M Gunnink; Benjamin D Kuiper; Ola D Alabi
Journal:  Biochimie       Date:  2012-11-27       Impact factor: 4.079

9.  New acyloxy nitroso compounds with improved water solubility and nitroxyl (HNO) release kinetics and inhibitors of platelet aggregation.

Authors:  Heba A H Mohamed; Mohamed Abdel-Aziz; Gamal El-Din A A Abuo-Rahma; S Bruce King
Journal:  Bioorg Med Chem       Date:  2015-04-16       Impact factor: 3.641

10.  Direct and nitroxyl (HNO)-mediated reactions of acyloxy nitroso compounds with the thiol-containing proteins glyceraldehyde 3-phosphate dehydrogenase and alkyl hydroperoxide reductase subunit C.

Authors:  Susan Mitroka; Mai E Shoman; Jenna F DuMond; Landon Bellavia; Omar M Aly; Mohamed Abdel-Aziz; Daniel B Kim-Shapiro; S Bruce King
Journal:  J Med Chem       Date:  2013-08-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.